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ABSTRACT
Generalized arterial calcification of infancy (GACI) is a life-threatening disorder in young infants. 
Cardiovascular symptoms are usually apparent within the first month of life. The symptoms are caused by 
calcification of large and medium-sized arteries, including the aorta, coronary arteries, and renal arteries. 
Most of the patients die by 6 months of age because of heart failure. Recently, homozygous or compound 
heterozygous mutations for the ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) gene were 
reported as causative for the disorder. ENPP1 regulates extracellular inorganic pyrophosphate (PPi), a major 
inhibitor of extracellular matrix calcification. A newborn was diagnosed with GACI. The infant died at the 
age of 7 weeks of cardiac failure and the parents were referred to Molecular Biology and Cytogenetic lab 
for further workup. Cytogenetics analysis was performed on the parents, which showed normal karyotypes 
and mutational analysis for the ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) gene was 
also performed. The mutational analysis showed that both father and mother of the deceased infant were 
heterozygous carriers of the mutation c.749C>T (p.P250L) in exon 7 of ENPP1 and it was likely, that the 
deceased child carried the same mutation homozygous on both alleles and died of GACI resulting from this 
ENPP1 mutation. The couple was counseled and monitored for the second pregnancy. Amniocentesis was 
performed at 15 weeks of gestation for mutational analysis of the same gene in the second pregnancy. The 
analysis was negative for the parental mutations. One month after the birth of a healthy infant, peripheral 
blood was collected from the baby and sent for reconfirmation. The results again were negative for the 
mutation and the baby was on 6 months follow up and no major symptoms were seen. The parents of the 
child benefited enormously by learning about the disease much in advance and also its risk of recurrence. The 
main aim of this study is to emphasize on two aspects: (i) the importance of modern molecular techniques 
in diagnosis such a syndrome and (2) the difficulties faced by the physician to provide appropriate diagnosis 
and the adequate genetic counseling to the family without molecular facilities.
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INTRODUCTION
Generalized arterial calcification of infancy (GACI) is 
a rare autosomal recessive disorder, reported till date 
in about 180 individuals.[1,2] Calcification of large and 
medium-sized arteries and marked myointimal proliferation 
leading to arterial stenoses, are characteristic vascular 
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features of the GACI phenotype. An extravascular feature 
of foci of periarticular calcification, occurs in many of 
the affected subjects.[3] Initial signs of the disease may 
occur prenatally and most affected children die in early 
infancy from sequelae of vascular occlusion, typically 
myocardial infarction or congestive heart failure due to 
hypertension.  [3,4] The diagnosis of GACI is often not 
considered until arterial calcification is incidentally detected 
in the affected patients. Also, arterial calcification might be 
too subtle to be detected by conventional radiography. In 
such cases, ultrasonography or computed tomography scan 
might demonstrate evidence of arterial calcification and 
establish the diagnosis.[5,6] Other potential causes of arterial 
calcium deposition, such as, hypervitaminosis D, advanced 
renal disease and hyperparathyroidism, can be excluded 
after basic laboratory investigations.[6] GACI is most 
frequently caused by mutations in ENPP1, a gene encoding 
ecto-nucleotide pyrophosphatase/phosphodiesterase 
1 (NPP1).[7] Prenatal diagnostic testing may not yield 
accurate results as the manifestations are usually seen only 
in the last trimester of pregnancy. However, early diagnosis 
by mutation analysis from amniocentesis is possible, if 
disease causing mutations in ENPP1 have been identified 
previously in an index case in the same family.
CASE REPORT
The parents of the index case were non-consanguineous. 
The antenatal ultra sonography during the pregnancy at 13 
and 30 weeks of gestation did not reveal any abnormalities. 
The 36 weeks ultrasonography revealed polyhydramnios 
and accumulation of mild pericardial effusion in the 
fetus [Figure 1a and 1b]. Amniotic fluid was drawn for 
chromosomal analysis during the 15 weeks of gestation 
which was normal, and unremarkable for numerical and 
structural anomalies. The female infant was born at term via 
lower-segment cesarean section. She developed respiratory 
distress immediately after birth and required supplemental 
oxygen. The baby was pale looking, hyperglycemic and 
euthermic. Vesicular breath sounds were audible. Abdomen 
was soft. A pansystolic murmur was heard at the 3rd and 4th 
left intercostal space. Central nervous system examination 
was unremarkable, and there were no external congenital 
anomalies. Her femoral pulses were present; however, 
brachial, radial, posterior tibial and dorsalis pedalis 
pulses were absent. Due to severe respiratory distress, 
she was initially started on continuous positive airway 
pressure (CPAP) ventilation; however, was later shifted 
to mechanical ventilation in view of increasing dyspnea 
and severe metabolic acidosis. In view of severe anemia 
[Table 1], she was given packed red blood cell transfusion.
She developed extreme tachycardia. Electrocardiography 
(ECG) on monitor was suggestive of ventricular 
fibrillation. Due to severe hypertensionand oxygen 
saturation of 95% in room air, she was started on 
Figure 1b: Single live intrauterine fetus at 36 weeks of gestation 
showing polyhydramnios (↔) and pericardial effusion (→)
Table 1: Clinical manifestations of the first child in the 
case report
Parameter Clinical manifestations
Symptoms Respiratory distress
Hypertension Blood pressure was 139/89 mmHg
Hemoglobin >8.0 g/dl
Chest 
radiograph
Revealed massive cardiomegaly with a 
calcified aorta
2 Dimensional 
Echocardiogram
Severe left ventricular dysfunction
Echocardiogram There was prominent calcification of the 
aortic arch, right pulmonary artery (RPA), 
innominate artery (IA), left carotid artery 
(LCA), and left subclavian artery
Ultra sound Revealed polyhydramnios and accumulation 
of mild pericardial effusion in the fetus
Figure 1a: Single live intrauterine fetus at 36 weeks of gestation without 
polyhydramnios and pericardial effusion152  Journal of Cardiovascular Disease Research Vol. 3 / No 2
Kalal, et al.: Molecular diagnosis of GACI
intravenous (IV) Furosemide. Chest radiograph revealed 
a massive cardiomegaly with a calcified aorta.A 2D Echo 
revealed severe left ventricular dysfunction [Figure 2]. 
She was started on Milrinone infusion and the dose was 
gradually increased to 0.9 micrograms per/kg per minute 
with minimal improvement.A repeat echocardiogram on 
the 49th day of life revealed severe biventricular dysfunction. 
The ascending aortic arch and the coronary arteries 
were calcified [Figure 2]. She was started on inotropic 
support (dobutamine and milrinone) and diuretic therapy. 
An ultrasound scan of the abdomen revealed a diffuse 
calcification of abdominal wall with right artery stenosis. A 
CT scan of abdomen revealed a diffuse rim calcification of 
the entire aorta and its branches in the chest and abdomen, 
and this pointed towards a rare genetic form of diffuse 
arterial calcification. The clinical diagnosis of generalized 
arterial calcification of infancy (GACI) was proposed, 
and therapy with IV Pamidronate (three doses given at 
0.9 micrograms per/kg per minute) was started at 18 days 
of life intravenously. Despite therapy, a rapid evolution to 
multiorgan failure and death occurred on day 51 of life. 
Autopsy was not performed as the parents did not give 
consent, and also mutational analysis of ENPP1 was not 
performed as no tissue was available.
The family was planning for the second conception; 
however, wanted to have an objective and measurable 
understanding about the risk of recurrence in a 
subsequent pregnancy. For this purpose the family was 
referred for a genetic counseling to the Molecular Biology 
and Cytogenetics lab, Apollo Hospitals, Hyderabad, India. 
After one year of the first baby’s demise, the mother 
conceived for the second time, and the pregnancy was 
closely monitored.A detailed genetic analysis was carried 
after taking the informed consent from the couple. About 
3 ml of peripheral blood sample was collected from the 
couple in a heparinized vacutainers and processed for 
cytogenetic analysis. Lymphocyte stimulated cultures 
were set up as described by Moorehead et al.[8] Giemsa 
banding (GTG banding) was performed according to 
Seabright et al.[9] Fifty metaphases were scored under 
light transmission microscope and karyotyping software 
(Leica CW 4000 Total solutions for cytogenetics imaging 
V1.3) was used for cytogenetic analysis. Metaphases were 
karyotyped according to International System for Human 
Cytogenetic Nomenclature (ISCN) criteria.[10] The 
cytogenetic analysis showed normal karyotype for both 
husband and wife without any numerical and structural 
anomalies. Peripheral blood sampling was repeated in 
the Ethylenediaminetetraacetic acid (EDTA) vacutainers 
and Deoxyribonucleic acid (DNA) was extracted using 
DNA extraction kit (Qiagen) and sent in the elution 
buffer for molecular analysis of ENPP1 in generalized 
arterial calcification. Mutation analysis of ENPP1 was 
performed with a set of 25 primer pairs, and all 25 
exons and their flanking splice sites of the ENPP1gene 
were amplified from genomic DNA by polymerase 
chain reaction (PCR). The PCR products were directly 
sequenced bidirectionally using a DNA analyzer (ABI 
3730) and a sequencing Kit (BigDye Terminator v1.1 
Cycle) according to the manufacturer’s protocol (Applied 
Biosystems). All primer sequences are available on 
request. Mutations were compared with the ENSEMBL 
polymorphism database.
Molecular analysis of the ENPP1gene in the DNA 
sample of both husband and wife showed that they were 
both heterozygous carriers for the mutation c.749C > T 
(p.P250L) in exon 7 of ENPP1. The mutation led to an 
amino acid change of proline to leucine at position 250 of 
the protein [Figure 3].
Wife: Exon 4: C517A>Cp.K173Q
  Exon 7: C749>T (p.P250L)
  Exon 13: C.1273-17delT
Husband: Exon 7: C.749>T (p.P250L)
  Exon 13: C.1273-17delT
All mutations were detected on one allele. The mutation 
c.517A> p.K173Q in exon 4 is known to be a non 
pathogenic polymorphism. The mutation c.1273-17delT is 
an intronic deletion in intron 12 and 17 base upstream of 
exon 13 which probably will not cause any transcriptional 
error (not been described previously) and is most likely not 
disease causing [Table 2 and Figure 3].
Figure 2: Echocardiogram at 49 day of the baby’s age showing that 
there was a prominent calcification of the aortic arch, right pulmonary 
artery (RPA), innominate artery (IA), left carotid artery (LCA), and left 
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During the second pregnancy at 15 gestational weeks, 
the amniocentesis was performed. The amniotic fluid 
was collected in two vials, and the first vial was cultured 
for cytogenetic analysis and the results showed a normal 
karyotype. From the second vial, the DNA was extracted 
and mutational analysis of exons 4 and 7 of ENPP1 
was performed from the fetal DNA, after exclusion of 
maternal contamination of the sample. Mutational analysis 
in the amniotic sample was negative for parental mutation 
(paternal mutation). After the baby was born, mutational 
analysis was repeated from a blood sample and again 
was confirmed to be negative for the parental mutation 
(paternal mutation) [Figure 3].
DISCUSSION
GACI is a rare, fatal, autosomal-recessive disorder that 
results in arterial stenosis and decreased elasticity of the 
blood-vessel walls, secondary to unregulated hydroxyapatite 
deposition. GACI is associated with inactivating mutations 
in the ENPP1 gene, which lead to decreased levels of 
inorganic pyrophosphate, a potent physiological inhibitor of 
hydroxyapatite-crystal deposition in the blood-vessel walls.[7] 
Till date, only 180 cases have been published on this disease, 
and, many cases go undiagnosed or unreported. GACI is 
associated with a high mortality rate owing to the development 
of severe hypertension and cardiovascular complications in 
early infancy. Several case studies have described patients 
who survived into adulthood with persistent hypertension 
and cardiovascular squealae; however, approximately 85% of 
affected infants do not survive beyond 6 months of age.  [6] 
Infants often present with nonspecific signs, including poor 
feeding, cyanosis and respiratory distress. The diagnosis of 
GACI is often not considered until arterial calcification is 
incidentally detected as in the index case presented here. 
Arterial calcification might be too subtle to be detected by 
conventional radiography. In such cases, ultrasonography or 
CT might demonstrate evidence of arterial calcification and 
establish the diagnosis.[5,6,11]
GACI should also be considered when hydrops fetalis is 
detected antenatally by ultrasonography as calcification 
is very rarely detected in the early stages of pregnancy. 
During pregnancy there might be polyhydramnios and 
mild pericardial effusion seen in the fetus is compared 
with normal, which was also present in our index case 
[Figure 1a and 1b]. The clinical presentation is variable, 
and most cases are diagnosed postmortem. Affected 
patients usually present with respiratory distress, feeding 
difficulties, hypertension and progressive heart failure.
Electrocardiography can reveal evidence of myocardial 
ischemia, which suggests coronary-artery involvement, 
and might also show ventricular hypertrophy or impaired 
ventricular function consistent with infarction.[11] Coronary 
artery involvement can be lethal within the first 6 months.  [12] 
The syndrome is histologically characterized by intima 
proliferation and diffuse deposition of hydroxyapatite 
at the internal elastic lamina of medium-sized arteries 
and correlates to the loss of function to mutations 
in the ENPP1 gene (chromosome 6q22–q23, OMIM 
173335), encoding for ectonucleotide pyrophosphatase/
phosphodiesterase 1 (NPP1). This cell surface enzyme 
is a type II membrane glycoprotein generating inorganic 
pyrophosphate PPiin vascular smooth muscle cells, 
chondrocytes and osteoblasts. PPi is a strong inhibitor of 
hydroxyapatite deposition. The pathogenesis of GACI is 
related to reduced NPP1 enzymatic activity leading to low 
extracellular PPi levels.[13-15]
Rutsch and colleagues demonstrated that homozygous 
or compound heterozygous loss-of-function mutations 
in ENPP1 result in GACI in about 80% of the cases.  [16] 
Accordingly, in the family presented here, ENPP1 
mutational analysis was performed in the parents of an 
index case with clinically proven GACI. The parents were 
found to be heterozygous carriers of two different ENPP1 
Table 2: Genotype mutation showing proband and the 
parents in the case report
Genotype mutation
Subjects Exon 7: C749>T (p.P250L)
Mother + (Heterozygous)
Father + (Heterozygous)
Subject 1 (1st deceased child) Test not performed as DNA 
not available
Subject 2 (2nd live child) - (No mutation detected)
Figure 3: Chromatograms of the DNA sequence of exon 7 of the 
ENPP1 gene in the affected family. Note heterozygosity for the 
c.749C>T mutation in ENPP1 in both of the parents154  Journal of Cardiovascular Disease Research Vol. 3 / No 2
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mutations. This makes is very likely that the deceased 
child must have been compound heterozygous for the 
same mutations. However, we were not able to prove this 
hypothesis, because there was no DNA available from the 
deceased child. The couple was counseled accordingly since 
they wanted another child.
It was reported earlier in 2009 that GACI is a rare autosomal 
recessive disorder and is characterized by vascular calcification 
and myointimal proliferation in infancy and thus results in 
stenosis and reduced vascular elasticity. There is an urgent 
need to use molecular tests to confirm the diagnosis and 
understand the risk-benefit ratio and also the potential risks 
involved. Genetic counseling for GACI is very important as 
the disease is transmitted in an autosomal recessive manner. 
Considering the objective evidence of risk of recurrence 
of ENPP1 mutations in a subsequent conceptus, the 
parents made a conscious decision to try to have another 
child. Although the clinical diagnosis of GACI is based on 
clinical features and typical radiographic signs, molecular 
analysis of ENPP1 is mandatory for genetic counseling in 
the affected family. Hence, it is recommended that along 
with investigations like CT, more advanced investigations 
such as fetal echo scan and molecular analysis of ENPP1 
should be included as this would help the clinicians and the 
prospective anxious parents to plan their families in a better 
way. In cases such as the present one, where a family has 
significant emotional and social issues to grapple with, the 
conflict as to whether to go for another pregnancy or not, 
can be answered with molecular diagnosis methods and the 
anxiety of the parents can be reduced. Given these concerns, 
a thorough explanation of the risk-benefit ratio should be 
considered whenever diagnostic tests are considered in 
patients with GACI, along with a detailed discussion with 
the parents about the potential risks involved.
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